Madame Bioscience Public Company Limited
Madame Bioscience Public Company Limited, together with its subsidiaries, manufactures and sells plastic packaging in Thailand. The company operates through three segments: Packaging business; Food business; and Other business. It offers various food products, including frozen and chilled, plant based, hemp, sauce, dried fruit, and processed foods products under the Kitchen plus, Viiva, and LookC… Read more
Madame Bioscience Public Company Limited (MADAME) - Net Assets
Latest net assets as of September 2025: ฿929.59 Million THB
Based on the latest financial reports, Madame Bioscience Public Company Limited (MADAME) has net assets worth ฿929.59 Million THB as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿1.81 Billion) and total liabilities (฿878.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿929.59 Million |
| % of Total Assets | 51.42% |
| Annual Growth Rate | -15.28% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 31.71 |
Madame Bioscience Public Company Limited - Net Assets Trend (2021–2024)
This chart illustrates how Madame Bioscience Public Company Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Madame Bioscience Public Company Limited (2021–2024)
The table below shows the annual net assets of Madame Bioscience Public Company Limited from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ฿538.80 Million | -30.68% |
| 2023-12-31 | ฿777.28 Million | -34.76% |
| 2022-12-31 | ฿1.19 Billion | +34.46% |
| 2021-12-31 | ฿886.03 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Madame Bioscience Public Company Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 10878361700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ฿1.63 Billion | 329.39% |
| Total Equity | ฿495.51 Million | 100.00% |
Madame Bioscience Public Company Limited Competitors by Market Cap
The table below lists competitors of Madame Bioscience Public Company Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aarti Surfactants Limited
NSE:AARTISURF
|
$15.14 Million |
|
Lapidoth
TA:LAPD
|
$15.14 Million |
|
National Capital Bank of Washington
PINK:NACB
|
$15.14 Million |
|
Ihlas Ev Aletleri Imalat Sanayi ve Ticaret AS
IS:IHEVA
|
$15.15 Million |
|
Courtside Group, Inc. Common Stock
NASDAQ:PODC
|
$15.14 Million |
|
Jeil M&S Co., Ltd
KQ:412540
|
$15.13 Million |
|
Ama Marine Public Company Limited
BK:AMA
|
$15.13 Million |
|
Agung Semesta Sejahtera Tbk PT
JK:TARA
|
$15.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Madame Bioscience Public Company Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 737,826,880 to 495,508,809, a change of -242,318,071 (-32.8%).
- Net loss of 332,038,156 reduced equity.
- New share issuances of 73,833,692 increased equity.
- Other factors increased equity by 15,886,393.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿-332.04 Million | -67.01% |
| Share Issuances | ฿73.83 Million | +14.9% |
| Other Changes | ฿15.89 Million | +3.21% |
| Total Change | ฿- | -32.84% |
Book Value vs Market Value Analysis
This analysis compares Madame Bioscience Public Company Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.16x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.70x to 4.16x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | ฿0.86 | ฿0.60 | x |
| 2022-12-31 | ฿0.74 | ฿0.60 | x |
| 2023-12-31 | ฿0.48 | ฿0.60 | x |
| 2024-12-31 | ฿0.14 | ฿0.60 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Madame Bioscience Public Company Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -67.01%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15.64%
- • Asset Turnover: 1.31x
- • Equity Multiplier: 3.26x
- Recent ROE (-67.01%) is below the historical average (-43.90%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -16.68% | -8.19% | 1.18x | 1.73x | ฿-243.84 Million |
| 2022 | -36.90% | -18.96% | 0.91x | 2.15x | ฿-536.77 Million |
| 2023 | -55.00% | -17.63% | 1.13x | 2.76x | ฿-479.59 Million |
| 2024 | -67.01% | -15.64% | 1.31x | 3.26x | ฿-381.59 Million |
Industry Comparison
This section compares Madame Bioscience Public Company Limited's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $1,744,237,767
- Average return on equity (ROE) among peers: 12.13%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Madame Bioscience Public Company Limited (MADAME) | ฿929.59 Million | -16.68% | 0.94x | $15.14 Million |
| Asian Alliance International PCL (AAI) | $4.88 Billion | 7.84% | 0.15x | $43.65 Million |
| ASIAN PALM OIL PUBLIC COMPANY LIMITED (APO) | $237.14 Million | 5.48% | 0.40x | $9.36 Million |
| Asian Sea Corporation Public Company Limited (ASIAN) | $3.50 Billion | 23.39% | 0.78x | $49.87 Million |
| Bioscience Animal Health PCL (BIS) | $790.50 Million | 6.41% | 0.55x | $4.82 Million |
| Seafresh Industry Public Company Limited (CFRESH) | $2.07 Billion | 0.95% | 1.32x | $8.09 Million |
| Chin Huay PCL (CH) | $1.37 Billion | 9.31% | 0.40x | $13.66 Million |
| CHAOSUA FOODS INDUSTRY PUBLIC COMPANY LIMITED (CHAO) | $597.83 Million | 27.03% | 0.46x | $12.59 Million |
| Kiang Huat Sea Gull Trading Frozen Food Public Company Limited (CHOTI) | $1.39 Billion | 14.18% | 0.11x | $3.48 Million |
| Chiangmai Frozen Foods Public Company Limited (CM) | $1.37 Billion | 7.17% | 0.11x | $6.08 Million |
| Thai Coconut Public Company Limited (COCOCO) | $1.24 Billion | 19.55% | 1.47x | $49.18 Million |